Time Lag of Glucose From Intravascular to Interstitial Compartment in Humans

The accuracy of continuous interstitial fluid (ISF) glucose sensing is an essential component of current and emerging open- and closed-loop systems for type 1 diabetes. An important determinant of sensor accuracy is the physiological time lag of glucose transport from the vascular to the interstitia...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 62; no. 12; pp. 4083 - 4087
Main Authors Basu, Ananda, Dube, Simmi, Slama, Michael, Errazuriz, Isabel, Amezcua, Jose Carlos, Kudva, Yogish C., Peyser, Thomas, Carter, Rickey E., Cobelli, Claudio, Basu, Rita
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.12.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The accuracy of continuous interstitial fluid (ISF) glucose sensing is an essential component of current and emerging open- and closed-loop systems for type 1 diabetes. An important determinant of sensor accuracy is the physiological time lag of glucose transport from the vascular to the interstitial space. We performed the first direct measurement of this phenomenon to our knowledge in eight healthy subjects under an overnight fasted condition. Microdialysis catheters were inserted into the abdominal subcutaneous space. After intravenous bolus administrations of glucose tracers, timed samples of plasma and ISF were collected sequentially and analyzed for tracer enrichments. After accounting for catheter dead space and assay noise, the mean time lag of tracer appearance in the interstitial space was 5.3–6.2 min. We conclude that in the overnight fasted state in healthy adults, the physiological delay of glucose transport from the vascular to the interstitial space is 5–6 min. Physiological delay between blood glucose and ISF glucose, therefore, should not be an obstacle to sensor accuracy in overnight or fasting-state closed-loop systems of insulin delivery or open-loop therapy assessment for type 1 diabetes.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0012-1797
1939-327X
1939-327X
DOI:10.2337/db13-1132